[go: up one dir, main page]

FR2850650B1 - Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures - Google Patents

Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures

Info

Publication number
FR2850650B1
FR2850650B1 FR0301144A FR0301144A FR2850650B1 FR 2850650 B1 FR2850650 B1 FR 2850650B1 FR 0301144 A FR0301144 A FR 0301144A FR 0301144 A FR0301144 A FR 0301144A FR 2850650 B1 FR2850650 B1 FR 2850650B1
Authority
FR
France
Prior art keywords
acylglycerols
nitrogen
therapeutic use
sulfur analogues
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0301144A
Other languages
English (en)
Other versions
FR2850650A1 (fr
Inventor
Raphael Darteil
Bertrand Karine Caumont
Jamila Najib
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genfit SA
Original Assignee
Genfit SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genfit SA filed Critical Genfit SA
Priority to FR0301144A priority Critical patent/FR2850650B1/fr
Priority to JP2006502128A priority patent/JP2006517954A/ja
Priority to EP04707252A priority patent/EP1587508A1/fr
Priority to US10/540,482 priority patent/US20060252827A1/en
Priority to CA002514301A priority patent/CA2514301A1/fr
Priority to PCT/FR2004/000229 priority patent/WO2004069241A1/fr
Publication of FR2850650A1 publication Critical patent/FR2850650A1/fr
Application granted granted Critical
Publication of FR2850650B1 publication Critical patent/FR2850650B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/28—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR0301144A 2003-01-31 2003-01-31 Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures Expired - Fee Related FR2850650B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0301144A FR2850650B1 (fr) 2003-01-31 2003-01-31 Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures
JP2006502128A JP2006517954A (ja) 2003-01-31 2004-02-02 アシルグリセロール並びにその窒素−及び硫黄含有類似物の治療上の使用
EP04707252A EP1587508A1 (fr) 2003-01-31 2004-02-02 Utilisation therapeutique d 'acylglycerols et de leurs analogues azotes et sulfures
US10/540,482 US20060252827A1 (en) 2003-01-31 2004-02-02 Therapeutic use of of acyglycerols and the nitrogen-and sulphur-containing analogues thereof
CA002514301A CA2514301A1 (fr) 2003-01-31 2004-02-02 Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures
PCT/FR2004/000229 WO2004069241A1 (fr) 2003-01-31 2004-02-02 Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0301144A FR2850650B1 (fr) 2003-01-31 2003-01-31 Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures

Publications (2)

Publication Number Publication Date
FR2850650A1 FR2850650A1 (fr) 2004-08-06
FR2850650B1 true FR2850650B1 (fr) 2005-03-25

Family

ID=32696261

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0301144A Expired - Fee Related FR2850650B1 (fr) 2003-01-31 2003-01-31 Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures

Country Status (6)

Country Link
US (1) US20060252827A1 (fr)
EP (1) EP1587508A1 (fr)
JP (1) JP2006517954A (fr)
CA (1) CA2514301A1 (fr)
FR (1) FR2850650B1 (fr)
WO (1) WO2004069241A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2828487B1 (fr) 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations
DE102006019907A1 (de) * 2006-04-28 2007-10-31 Müller-Enoch, Dieter, Prof. Dr. Verwendung von substituierten Glycerinderivaten zur Herstellung einer pharmazeutischen Zubereitung
DE102010029499A1 (de) * 2010-05-31 2011-12-01 Evonik Goldschmidt Gmbh Polyolpartialester zur Anwendung in Kosmetik
CN105985389B (zh) * 2015-03-06 2019-03-19 北京大学 苯乙醇苷类似物及其合成方法和应用
EP3982948A1 (fr) * 2019-06-11 2022-04-20 Rosi Charni AS Formulation de liposomes
CN111747851B (zh) * 2020-07-13 2023-07-18 桂林医学院 络石藤中具抗炎活性的甘油酯类化合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1271179A (en) * 1969-06-11 1972-04-19 Mitsubishi Petrochemical Co Polyolefin resin composition
IL59407A (en) * 1979-03-06 1983-12-30 Sanofi Sa Di-n-propylacetic acid diesters of glycerol,their preparation and pharmaceutical compositions containing them
JPH01153629A (ja) * 1987-12-11 1989-06-15 Nippon Oil & Fats Co Ltd 制癌剤
NO952796D0 (no) * 1995-07-14 1995-07-14 Rolf Berge Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
WO1999058120A1 (fr) * 1998-05-08 1999-11-18 Rolf Berge Utilisation d'analogues d'acides gras non beta-oxydables pour traiter les etats lies au syndrome x
FR2828487B1 (fr) * 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations

Also Published As

Publication number Publication date
EP1587508A1 (fr) 2005-10-26
WO2004069241A1 (fr) 2004-08-19
US20060252827A1 (en) 2006-11-09
JP2006517954A (ja) 2006-08-03
CA2514301A1 (fr) 2004-08-19
FR2850650A1 (fr) 2004-08-06

Similar Documents

Publication Publication Date Title
FR16C1012I2 (fr) Utilisation therapeutique d'anticorps anti-cs1
EP1608318A4 (fr) Antagonistes cxcr4 et leurs procedes d'utilisation
EP1638977A4 (fr) Salinosporamides et leurs methodes d'utilisation
EP1603567A4 (fr) Derives de benzamide tetracyclique et leurs procedes d'utilisation
EP1406653A4 (fr) Genes regulateurs de lymphocytes t et leurs methodes d'utilisation
EP1706791A4 (fr) Compositions de photoresines et leurs procedes d'utilisation
EP1603568A4 (fr) Derives d'isoquinoline et leurs methodes d'utilisation
EP1636250A4 (fr) Peptides autoassembles presentant des modifications et methodes d'utilisation des peptides
EP1453581A4 (fr) Jouets et jeux a reconnaissance d'objets
DK1404809T3 (da) Forbedrede hudsubstitutter og anvendelser deraf
EP1507541A4 (fr) Inhibiteurs et procedes d'utilisation de ceux-ci
DE69804793D1 (de) Klinisches und/oder chirurgisches trainingsgerät
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
PL374831A1 (pl) Zmodyfikowane proleki 2' i 3'-nukleozydowe do leczenia zakażeń Flaviviridae
MA29029B1 (fr) Composes de thiadiazole et leurs procedes d'utilisation
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
NO20024099D0 (no) Lavdose entecavir-formulering og anvendelse
DE60233192D1 (de) Hydrophobe und lipophobe zusammensetzung
EP1937268A4 (fr) Analogues d'indenoisoquinolinone et leurs procedes d'utilisation
EP1487469A4 (fr) Co-granule de dha et de romarin et procedes d'utilisation associes
EP1539778A4 (fr) Deprotection et purification d'oligonucleotides et de leurs derives
EP1838331A4 (fr) Peptides antimicrobiens et procedes d'utilisation associes
EP1476150A4 (fr) Carboxyfullerenes et procedes d'utilisation de ceux-ci
EP1638513A4 (fr) Substances insaponifiables en teneur elevee et leurs procedes d'utilisation
EP1644323A4 (fr) Inhibiteurs d'histone desacetylase et leurs procedes d'utilisation

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091030